Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,485.00
Bid: 2,475.00
Ask: 2,485.00
Change: 30.00 (1.22%)
Spread: 10.00 (0.404%)
Open: 2,435.00
High: 2,490.00
Low: 2,425.00
Prev. Close: 2,455.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Steve Crummett as Finance Director

10 Jan 2013 07:00

RNS Number : 2188V
Morgan Sindall Group PLC
10 January 2013
 



 

10 January 2013

 

Morgan Sindall Group plc: Appointment of Steve Crummett as Finance Director

 

The Board of Morgan Sindall Group plc ('Morgan Sindall' or the 'Group') today announces the appointment of Steve Crummett as Finance Director with effect from 25 February 2013. Current Finance Director, David Mulligan, has indicated that, after fifteen years with the Group, he would like to step down from his current role to pursue new challenges and, with the appointment of Steve Crummett, he will be leaving the Group on 10 April 2013 following a handover period.

 

Steve Crummett was most recently the Group Finance Director at Filtrona plc, a position he held from 2008. Prior to Filtrona, Steve held senior positions in a number of listed companies including Exel plc, Mckechnie plc and Logica plc. He qualified as a Chartered Accountant with Arthur Andersen. Steve is also a Non-Executive Director of Consort Medical plc.

 

Chairman, Adrian Martin, said:

 

'On behalf of the Board I would like to thank David Mulligan for his significant contribution and commitment to Morgan Sindall over the past fifteen years. In his time with us, David has been instrumental in developing strong reporting disciplines and controls and has been a collaborative and supportive member of the team.

 

I am delighted that we have recruited a person of Steve Crummett's calibre as Finance Director. He has gained substantial and wide-ranging experience across a number of businesses and has valuable and significant skills which are relevant to Morgan Sindall as the business continues to focus on growth opportunities for the medium to longer-term.'

 

 

 

-Ends -

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Crummett's appointment.

 

 

Morgan Sindall Group plc Tel: 020 7307 9200

Adrian Martin, Chairman

John Morgan, Chief Executive

 

Brunswick Tel: 0207 404 5959

Jonathan Glass

Nick Cosgrove

 

Notes to Editors:

 

Biography of Steve Crummett

 

From March 2008 to September 2012, Steve was the Group Finance Director of Filtrona plc, the FTSE 250 leading supplier of specialty plastic, fibre and foam products and was responsible for Finance, Tax, Treasury, IT, Internal Audit and Risk. From May 2007 to March 2008 he was Director of Corporate Development at Filtrona. Prior to Filtrona, Steve was at Exel plc from 2003 to 2006, through its acquisition by Deutsche Post. From 1997 to 2002, Steve was Head of Corporate Development at McKechnie plc, and Corporate Finance Manager at Logica plc from 1995 to 1997. He qualified as a Chartered Accountant with Arthur Andersen.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 7,000 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGGMLLVGFZM
Date   Source Headline
14th May 20243:08 pmRNSDirector/PDMR Shareholding
2nd May 20242:09 pmRNSResult of AGM
2nd May 20247:00 amRNSTrading Update
1st May 20249:40 amRNSTotal Voting Rights
22nd Apr 202410:35 amRNSBlock listing Interim Review
8th Apr 20247:00 amRNSDirectorate Changes: Update
2nd Apr 202412:38 pmRNSTotal Voting Rights
21st Mar 20242:17 pmRNSAnnual Financial Report
19th Mar 20243:45 pmRNSAdditional Listing
5th Mar 20243:05 pmRNSDirector/PDMR Shareholding
5th Mar 20243:04 pmRNSDirector/PDMR Shareholding
5th Mar 20242:53 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
1st Mar 20243:19 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSRESULTS FOR THE FULL YEAR ENDED 31 DECEMBER 2023
5th Feb 20247:00 amRNSNotice of Full Year Results
1st Feb 202410:25 amRNSTotal Voting Rights
19th Jan 20244:14 pmRNSHolding(s) in Company
17th Jan 20245:11 pmRNSHolding(s) in Company
12th Jan 20243:25 pmRNSHolding(s) in Company
2nd Jan 202412:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSDirectorship Changes
7th Dec 20235:40 pmRNSHolding(s) in Company
6th Dec 20234:33 pmRNSHolding(s) in Company
1st Dec 202312:13 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSDirectorship Changes
22nd Nov 20232:31 pmRNSAdditional Listing
3rd Nov 20234:15 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSTrading Update
1st Nov 202311:14 amRNSTotal Voting Rights
26th Oct 20234:43 pmRNSHolding(s) in Company
20th Oct 20239:05 amRNSBlock listing Interim Review
10th Oct 202311:44 amRNSAdditional Listing
12th Sep 20233:12 pmRNSHolding(s) in Company
4th Sep 202312:51 pmRNSAGM Voting Update
1st Sep 20239:45 amRNSTotal Voting Rights
22nd Aug 20233:56 pmRNSAdditional Listing
10th Aug 202311:50 amRNSDirector/PDMR Shareholding
10th Aug 202311:45 amRNSDirector/PDMR Shareholding
2nd Aug 20236:30 pmRNSResults for the Half Year (HY) Ended 30 June 2023
1st Aug 202311:13 amRNSTotal Voting Rights
10th Jul 20237:00 amRNSNotice of Half Year Results
3rd Jul 202310:37 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSTrading Update
14th Jun 20232:10 pmRNSAdditional Listing
14th Jun 20239:13 amRNSHolding(s) in Company
12th Jun 20233:50 pmRNSHolding(s) in Company
1st Jun 20239:16 amRNSTotal Voting Rights
31st May 20234:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.